Zymeworks (ZYME) Gains from Investment Securities: 2021-2023
Historic Gains from Investment Securities for Zymeworks (ZYME) over the last 2 years, with Dec 2023 value amounting to $978,000.
- Zymeworks' Gains from Investment Securities fell 90.46% to $978,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $12.2 million, marking a year-over-year decrease of 93.56%. This contributed to the annual value of $3.2 million for FY2024, which is 67.32% up from last year.
- According to the latest figures from Q4 2023, Zymeworks' Gains from Investment Securities is $978,000, which was up 131.21% from $423,000 recorded in Q3 2023.
- In the past 5 years, Zymeworks' Gains from Investment Securities registered a high of $178.7 million during Q4 2021, and its lowest value of -$25.3 million during Q1 2022.
- In the last 3 years, Zymeworks' Gains from Investment Securities had a median value of $978,000 in 2023 and averaged $27.2 million.
- In the last 5 years, Zymeworks' Gains from Investment Securities plummeted by 94.26% in 2022 and then soared by 101.97% in 2023.
- Zymeworks' Gains from Investment Securities (Quarterly) stood at $178.7 million in 2021, then crashed by 94.26% to $10.2 million in 2022, then plummeted by 90.46% to $978,000 in 2023.
- Its Gains from Investment Securities was $978,000 in Q4 2023, compared to $423,000 in Q3 2023 and $499,000 in Q1 2023.